Real-World Assessment of Efficacy and Safety Parameters for Dapagliflozin in Management of Type 2 Diabetes Mellitus: REWARD Study

Real-World Assessment of Efficacy and Safety Parameters for Dapagliflozin in Management of Type 2 Diabetes Mellitus: REWARD Study

Introduction: While ample evidence on improved glycemic control, weight reduction, and lowered blood pressure (BP) with sodium-glucose cotransporter type 2 inhibitors (SGLT2is) exists, real-world data on the potential benefit of SGLT2i on the diabetic population in the Middle East are lacking. The a...

Full description

Bibliographic Details
Main Authors: Ahmed Hassoun, Denish Kumar Dhanwal, Jalal Nafach, Yasmin Ajaz, Asif Majid Khan, Abdullah Ben Nakhi, Monira AlArouj, Khadija Hafidh, Majdi AlNajjar, Ahmed Reyas, Sana Qamar, Mohamed Alsayed, Ahmad Bdair
Format: Article
Language:English
Published: Karger Publishers 2022-01-01
Series:Dubai Diabetes and Endocrinology Journal
Subjects:
dapagliflozin
sodium-glucose cotransporter type 2
sodium-glucose cotransporter type 2 inhibitors
diabetes mellitus
type 2 diabetes mellitus
type 2 diabetes
Online Access:https://www.karger.com/Article/FullText/519871

Internet

https://www.karger.com/Article/FullText/519871

Similar Items